Literature DB >> 1315121

Wheat-bran and oat-bran supplements' effects on blood lipids and lipoproteins.

H Kashtan1, H S Stern, D J Jenkins, A L Jenkins, K Hay, N Marcon, S Minkin, W R Bruce.   

Abstract

To compare the effects of oat-bran fiber on blood lipids, we studied 84 healthy middle-aged men and women who were placed on metabolic diets, for 2 wk, that were supplemented with either wheat bran (n = 42) or oat bran (n = 42). Fiber supplementation was 1.6 micrograms dietary fiber/J (6.8 g dietary fiber/1000 kcal) to a maximum of 16.4 g fiber/d. Significantly greater decrease with oat than with wheat were seen in total cholesterol (0.56 +/- 0.08 mmol/L and 0.29 +/- 0.08 mmol/L, P = 0.022) and low-density-lipoprotein cholesterol (0.39 +/- 0.07 mmol/L and 0.15 +/- 0.07 mmol/L, P = 0.024). No significant differences were seen in high-density lipoprotein, apolipoproteins A-1 and B, or triglyceride. We conclude that oat bran has an advantage over wheat bran in lowering serum lipids when tested in metabolic diets on large numbers of individuals with an initial mean serum cholesterol concentration above the desirable range, at 5.61 +/- 0.16 mmol/L.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315121     DOI: 10.1093/ajcn/55.5.976

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  3 in total

1.  Effects of amylose and wheat bran on the levels of blood serum urea nitrogen (BUN), other blood parameters, growth and fecal characteristics in rats.

Authors:  R Mongeau; G Sarwar; R Brassard; H G Botting
Journal:  Plant Foods Hum Nutr       Date:  1995-09       Impact factor: 3.921

Review 2.  Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA-I Metabolism: A Systematic Overview.

Authors:  Lotte Smolders; Jogchum Plat; Ronald P Mensink
Journal:  J Nutr Metab       Date:  2017-06-12

Review 3.  Effect of oat supplementation interventions on cardiovascular disease risk markers: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Erand Llanaj; Gordana M Dejanovic; Hua Kern; Taulant Muka; Ezra Valido; Arjola Bano; Magda Gamba; Lum Kastrati; Beatrice Minder; Stevan Stojic; Trudy Voortman; Pedro Marques-Vidal; Jivko Stoyanov; Brandon Metzger; Marija Glisic
Journal:  Eur J Nutr       Date:  2022-01-03       Impact factor: 4.865

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.